Literature DB >> 22733364

Co-location of HDAC2 and insulin signaling components in the adult mouse hippocampus.

Zhi-Gang Yao1, Yu Liu, Ling Zhang, Lan Huang, Chun-Mei Ma, Yan-Feng Xu, Hua Zhu, Chuan Qin.   

Abstract

As one part of epigenetics, histone deacetylases (HDACs) have been demonstrated to get into the neural events, including neurogenesis, synaptic plasticity, and neurodegeneration through regulating acetylation status of target proteins to influence protein function and gene expression. However, the recent studies indicated that HDAC2, a member of HDACs family, played a role in insulin signaling pathway and synaptic plasticity. Here, we are concerned about whether HDAC2 was co-located with insulin signaling components in postsynaptic glutamatergic neurons (PSGNs) of the adult mouse hippocampus using double immunofluorescence staining. The results displayed that HDAC2 was present in PSGNs marked by N-methyl-D-aspartate receptor subunit 2B, in which major components of insulin signaling pathway such as insulin receptor alpha and beta and insulin receptor substrate-1 were also involved. Accordingly, we speculate that the interaction of HDAC2 and insulin signaling system in PSGNs observed in the present study may serve as a potential mechanism in memory formation. We hope this could provide a valuable basis for understanding the roles of HDAC2 and insulin on cognitive impairment of diabetes mellitus, involved Alzheimer's disease, which is also called type 3 diabetes recently. And this will also benefit to the treatment of insulin-related diseases in the central nervous system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22733364     DOI: 10.1007/s10571-012-9859-6

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  46 in total

Review 1.  Signaling pathways in insulin action: molecular targets of insulin resistance.

Authors:  J E Pessin; A R Saltiel
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Type 2 diabetes and late-onset Alzheimer's disease.

Authors:  D Cheng; J Noble; M X Tang; N Schupf; R Mayeux; J A Luchsinger
Journal:  Dement Geriatr Cogn Disord       Date:  2011-07-15       Impact factor: 2.959

3.  A preformed complex of postsynaptic proteins is involved in excitatory synapse development.

Authors:  Kimberly Gerrow; Stefano Romorini; Shahin M Nabi; Michael A Colicos; Carlo Sala; Alaa El-Husseini
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

4.  Rosiglitazone effects to ameliorate Alzheimer's disease pathogenic features: insulin signaling and neurotrophic factors.

Authors:  Jorge I Castillo-Quan
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2009       Impact factor: 2.198

5.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

Authors:  Konrad Talbot; Hoau-Yan Wang; Hala Kazi; Li-Ying Han; Kalindi P Bakshi; Andres Stucky; Robert L Fuino; Krista R Kawaguchi; Andrew J Samoyedny; Robert S Wilson; Zoe Arvanitakis; Julie A Schneider; Bryan A Wolf; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  J Clin Invest       Date:  2012-04       Impact factor: 14.808

6.  Hippocampal synaptic plasticity in streptozotocin-diabetic rats: impairment of long-term potentiation and facilitation of long-term depression.

Authors:  A Kamal; G J Biessels; I J Urban; W H Gispen
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

7.  Insulin modulates hippocampal activity-dependent synaptic plasticity in a N-methyl-d-aspartate receptor and phosphatidyl-inositol-3-kinase-dependent manner.

Authors:  Lars P van der Heide; Amer Kamal; Alain Artola; Willem Hendrik Gispen; Geert M J Ramakers
Journal:  J Neurochem       Date:  2005-08       Impact factor: 5.372

8.  Distribution of NMDA receptor subunit NR1 in arctic ground squirrel central nervous system.

Authors:  Huiwen W Zhao; Sherri L Christian; Marina R Castillo; Abel Bult-Ito; Kelly L Drew
Journal:  J Chem Neuroanat       Date:  2006-11-09       Impact factor: 3.052

9.  Impaired insulin secretion increases the risk of Alzheimer disease.

Authors:  E Rönnemaa; B Zethelius; J Sundelöf; J Sundström; M Degerman-Gunnarsson; C Berne; L Lannfelt; L Kilander
Journal:  Neurology       Date:  2008-04-09       Impact factor: 9.910

10.  HDAC2 negatively regulates memory formation and synaptic plasticity.

Authors:  Ji-Song Guan; Stephen J Haggarty; Emanuela Giacometti; Jan-Hermen Dannenberg; Nadine Joseph; Jun Gao; Thomas J F Nieland; Ying Zhou; Xinyu Wang; Ralph Mazitschek; James E Bradner; Ronald A DePinho; Rudolf Jaenisch; Li-Huei Tsai
Journal:  Nature       Date:  2009-05-07       Impact factor: 49.962

View more
  7 in total

Review 1.  Folate and epigenetic mechanisms in neural tube development and defects.

Authors:  Sivan Vadakkadath Meethal; Kirk J Hogan; Chandra S Mayanil; Bermans J Iskandar
Journal:  Childs Nerv Syst       Date:  2013-09-07       Impact factor: 1.475

2.  Maternal Separation-Induced Histone Acetylation Correlates with BDNF-Programmed Synaptic Changes in an Animal Model of PTSD with Sex Differences.

Authors:  Haoran Sun; Xianqiang Zhang; Yujia Kong; Luping Gou; Bo Lian; Yanyu Wang; Li Jiang; Qi Li; Hongwei Sun; Lin Sun
Journal:  Mol Neurobiol       Date:  2020-11-27       Impact factor: 5.590

3.  Natural Selection and Functional Potentials of Human Noncoding Elements Revealed by Analysis of Next Generation Sequencing Data.

Authors:  Pankaj Jha; Dongsheng Lu; Shuhua Xu
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

Review 4.  The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer's disease.

Authors:  Shuang-Shuang Yang; Rui Zhang; Gang Wang; Yong-Fang Zhang
Journal:  Transl Neurodegener       Date:  2017-07-10       Impact factor: 8.014

5.  Histone deacetylase-2 is involved in stress-induced cognitive impairment via histone deacetylation and PI3K/AKT signaling pathway modification.

Authors:  Jie Wu; Cui Liu; Ling Zhang; Chun-Hui Qu; Xiao-Long Sui; Hua Zhu; Lan Huang; Yan-Feng Xu; Yun-Lin Han; Chuan Qin
Journal:  Mol Med Rep       Date:  2017-06-22       Impact factor: 2.952

Review 6.  The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases.

Authors:  Dihe Cheng; Shuo Yang; Xue Zhao; Guixia Wang
Journal:  Drug Des Devel Ther       Date:  2022-03-14       Impact factor: 4.162

7.  Spatiotemporal expression of HDAC2 during the postnatal development of the rat hippocampus.

Authors:  Nali Hou; Min Gong; Yang Bi; Yun Zhang; Bin Tan; Youxue Liu; Xiaoping Wei; Jie Chen; Tingyu Li
Journal:  Int J Med Sci       Date:  2014-05-30       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.